IBC Meeting Schedule and Protocol Submission
Who needs to be registered with Institutional Biosafety Committee (IBC)?
All work involving biohazard agents, recombinant and/or synthetic nucleic acid molecules, use of human blood, body fluids or tissues, gene therapy, use of USDA agents or CDC select agents must be registered and, in some cases, approved by the Institutional Biosafety Committee (IBC) prior to initiation of work. It is the responsibility of the Principal Investigator to submit a completed IBC application/registration to the Institutional Biosafety Committee
IBC Protocol submission process (NEW)
IBC Protocol submission forms (NEW)
IBC meeting schedule
The deadline allows sufficient time for revision of the draft submission to ensure an administratively complete application is available to the committee in an effort to expedite review and approval. Incomplete submissions may necessitate a delay in consideration to a subsequent meeting. For questions regarding the protocol submission process, please contact the Bio Safety Program Office (email@example.com).
IBC meets on the third Wednesday of every month from 12 Noon to 1 p.m.
|IBC Protocol Submission Due Date||IBC Meeting date|
|January 25, 2023||February 15, 2023|
|February 22, 2023||March 15, 2023|
|March 22, 2023||April 19, 2023|
|April 26, 2023||May 17, 2023|
|May 24, 2023||June 21, 2023|
|June 28, 2023||July 20, 2023|
|July 27, 2023||August 16, 2023|
|August 23, 2023||September 20, 2023|
|September 27, 2023||October 18, 2023|
|October 25, 2023||November 15, 2023|
|November 22, 2023||December 20, 2023|
|December 27, 2023||January 17, 2024|